000 01290 a2200337 4500
005 20250516212440.0
264 0 _c20150928
008 201509s 0 0 eng d
022 _a1464-3405
024 7 _a10.1016/j.bmcl.2014.04.043
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRevelant, Germain
245 0 0 _aSynthesis and antiproliferative studies of 5-aryl-2-(3-thienylamino)-1,3,4-thiadiazoles.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cJun 2014
300 _a2724-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xchemical synthesis
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Screening Assays, Antitumor
650 0 4 _aHumans
650 0 4 _aInhibitory Concentration 50
650 0 4 _aThiadiazoles
_xchemical synthesis
700 1 _aGadais, Charlène
700 1 _aMathieu, Véronique
700 1 _aKirsch, Gilbert
700 1 _aHesse, Stéphanie
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 24
_gno. 12
_gp. 2724-7
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2014.04.043
_zAvailable from publisher's website
999 _c23813624
_d23813624